References
- Thorley-Lawson DA. Epstein–Barr virus: exploiting the immune system. Nat Rev Immunol 2001;1:75–82.
- Swerdlow SH, Webber SA, Chadburn A, Ferry JA. Post-transplant lymphoproliferative disorders. In: Swerdlow SH, Campo E, Harris NL, et al, editors. WHO Classification Of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2008. pp 343–349.
- Weinstock DM, Ambrossi GG, Brennan C, Kiehn TE, Jakubowski A. Preemptive diagnosis and treatment of Epstein-Barr virus-associated post transplant lymphoproliferative disorder after hematopoietic stem cell transplant: an approach in development. Bone Marrow Transplant 2006;37:539–546.
- Zoufaly A, Stellbrink HJ, Heiden MA, et al ClinSurv study group. Cumulative HIV viremia during highly active antiretroviral therapy is a strong predictor of AIDS-related lymphoma. J Infect Dis 2009;200:79–87.
- Gaulard P, Swerdlow SH, Harris NL, Jaffe ES, Sundström C. Other iatrogenic immunodeficiency-associated lymphoproliferative disorders. In: Swerdlow SH, Campo E, Harris NL, et al, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon, France: IARC Press; 2008. pp 350–351.
- Kandiel A, Fraser AG, Korelitz BI, Brensinger C, Lewis JD. Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine. Gut 2005;54:1121–1125.
- Rosh JR, Gross T, Mamula P, Griffiths A, Hyams J. Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohn's disease: a cautionary tale? Inflamm Bowel Dis 2007;13:1024–1030.
- Baecklund E, Iliadou A, Askling J, et al Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum 2006;54:692–701.
- Pittaluga S, Wilson WH, Jaffe ES. Lymphomatoid granulomatosis. In: Swerdlow SH, Campo E, Harris NL, et al, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon, France: IARC Press; 2008. pp 247–249.
- N'guyen Y, Andreoletti L, Patey M, et al Fatal Epstein–Barr virus primo infection in a 25-year-old man treated with azathioprine for Crohn's disease. J Clin Microbiol 2009;47:1252–1254.
- Castiglione F, Del Vecchio Blanco G, Rispo A, et al Hepatitis related to cytomegalovirus infection in two patients with Crohn's disease treated with azathioprine. Dig Liver Dis 2000;32:626–629.
- Vergara M, Brullet E, Campo R, Calvet X, Blanch L. Fulminant infection caused by varicella herpes zoster in patient with Crohn disease undergoing treatment with azathioprine. Gastroenterol Hepatol 2001;24:47.
- Meijer E, Cornelissen JJ. Epstein–Barr virus-associated lymphoproliferative disease after allogenic haematpoietic stem cell transplantation: molecular monitoring and early treatment of high-risk patients. Curr Opin Hematol 2008;15:576–585.
- Grothey A, Grothe W, Kegel T, Wol HH, Schmoll HJ. Successful treatment of mediastinal lymphomatoid granulomatosis with rituximab monotherapy. Eur J Haematol 2005;74:263–266.
- Polizzotto MN, Dawson MA, Opat SS. Failure of rituximab monotherapy in lymphomatoid granulomatosis. Eur J Haematol 2005;75:172–173.